Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P200045/S016

RelayPro Thoracic Stent-Graft System

Bolton Medical, Inc. · Decision date Jul 22, 2025

FDA DECISIONP200045/S016

What did the FDA approve?

FDA records P200045/S016 as a supplement to PMA P200045, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Jul 22, 2025.

FDA approval order statement

Approval for extension of shelf-life to 3-years
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Cardiovascular
Decision date
Jul 22, 2025
FDA change category
Labeling Change - Indications/instructions/shelf life/tradename

FDA source record

Regulatory record facts

Identifier
P200045/S016
Regulatory pathway
PMA supplement
Product code
MIH
Decision code
APPR
Decision date
Jul 22, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT.

Product code
MIH
FDA device class
3

For the original device and its historical approval scope, see PMA P200045. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P200045 · Original PMA

    RelayPro Thoracic Stent-Graft System

  2. P200045/S016 received

    Application receipt date recorded by FDA.

  3. P200045/S016 · FDA decision

    Real-Time Process

  4. P200045/S020 · Related supplement

    RelayPro Thoracic Stent-Graft System

  5. P200045/S018 · Related supplement

    RelayPro Thoracic Stent-Graft System

  6. P200045/S022 · Related supplement

    RelayPro Thoracic Stent-Graft System

  7. P200045/S017 · Related supplement

    RelayPro Thoracic Stent-Graft System

  8. P200045/S024 · Related supplement

    RelayPro Thoracic Stent-Graft System

  9. P200045/S025 · Related supplement

    RelayPro Thoracic Stent-Graft Delivery System

Timeline entries are records held by MedtechLedger for P200045. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P200045

Product / regulatory recordCompanyPathwayDecision dateSource
Bolton Medical, Inc.PMA approvalAug 5, 2021FDA
RelayProP200045/S019
Bolton Medical, Inc.PMA supplementSep 3, 2025FDA
Bolton Medical, Inc.PMA supplementSep 10, 2025FDA
Bolton Medical, Inc.PMA supplementOct 7, 2025FDA
Bolton Medical, Inc.PMA supplementFeb 19, 2026FDA
Bolton Medical, Inc.PMA supplementApr 13, 2026FDA
Bolton Medical, Inc.PMA supplementJun 18, 2026FDA
Bolton Medical, Inc.PMA supplementOct 28, 2026FDA

Explore the linked device profile

Other records with product code MIH

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Bolton Medical, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
799 International Pkwy., Sunrise, FL, 33325

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records